Evaluation of Markers of Oxidative Stress, Antioxidant Function and Astrocytic Proliferation in the Striatum and Frontal Cortex of Parkinson’s Disease Brains (original) (raw)
Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442 PubMedCAS Google Scholar
Adams JD Jr, Chang ML, Klaidman L (2001) Parkinson’s disease–redox mechanisms. Curr Med Chem 8:809–814 PubMedCAS Google Scholar
Beal MF (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol 31:119–130 ArticlePubMedCAS Google Scholar
Jenner P, Dexter DT, Sian J et al. (1992) Oxidative stress as a cause of nigral cell death in Parkinson’s disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson’s Disease Research Group. Ann Neurol 32(Suppl): S82–S87 Google Scholar
Koiliatsos VE (1998) Parkinson’s disease. In: Burke RE (ed) Cell death and disease of the nervous system. Humana Press, Totowa, pp 459–475 Google Scholar
Sayre LM, Smith MA, Perry G (2001) Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr Med Chem 8:721–738 PubMedCAS Google Scholar
Bharath S, Hsu M, Kaur D et al (2002) Glutathione, iron and Parkinson’s disease. Biochem Pharmacol 64:1037–1048 ArticlePubMedCAS Google Scholar
Dexter DT, Carter CJ, Wells FR et al (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson’s disease. J Neurochem 52:381–389 ArticlePubMedCAS Google Scholar
Yoritaka A, Hattori N, Uchida K et al (1996) Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci USA 93:2696–2701 ArticlePubMedCAS Google Scholar
Alam ZI, Jenner A, Daniel SE et al (1997) Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J Neurochem 69:1196–1203 ArticlePubMedCAS Google Scholar
Dexter DT, Wells FR, Lees AJ et al (1989) Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson’s disease. J Neurochem 52:1830–1836 ArticlePubMedCAS Google Scholar
Sofic E, Paulus W, Jellinger K et al (1991) Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J Neurochem 56:978–982 ArticlePubMedCAS Google Scholar
Alam ZI, Daniel SE, Lees AJ et al (1997) A generalised increase in protein carbonyls in the brain in Parkinson’s but not incidental Lewy body disease. J Neurochem 69:1326–1329 ArticlePubMedCAS Google Scholar
Floor E, Wetzel MG (1998) Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay. J Neurochem 70:268–275 ArticlePubMedCAS Google Scholar
Good PF, Hsu A, Werner P et al (1998) Protein nitration in Parkinson’s disease. J Neuropathol Exp Neurol 57:338–342 ArticlePubMedCAS Google Scholar
Blanchard-Fillion B, Prou D, Polydoro M et al (2006) Metabolism of 3-nitrotyrosine induces apoptotic death in dopaminergic cells. J Neurosci 26:6124–6130 ArticlePubMedCAS Google Scholar
Danielson SR, Andersen JK (2008) Oxidative and nitrative protein modifications in Parkinson’s disease. Free Radic Biol Med 44:1787–1794 ArticlePubMedCAS Google Scholar
Ferrante RJ, Hantraye P, Brouillet E et al (1999) Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP treated baboons is blocked by inhibition of neuronal nitric oxide synthase. Brain Res 823:177–182 ArticlePubMedCAS Google Scholar
Hasegawa E, Takeshige K, Oishi T et al (1990) 1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles. Biochem Biophys Res Commun 170:1049–1055 ArticlePubMedCAS Google Scholar
Ischiropoulos H, Beckman JS (2003) Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J Clin Invest 111:163–169 PubMedCAS Google Scholar
Pennathur S, Jackson-Lewis V, Przedborski S et al (1999) Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o, o’-dityrosine in brain tissue of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson’s disease. J Biol Chem 274:34621–34628 ArticlePubMedCAS Google Scholar
Keeney PM, Xie J, Capaldi RA et al (2006) Parkinson’s disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci 26:5256–5264 ArticlePubMedCAS Google Scholar
Schapira AH, Cooper JM, Dexter D et al (1990) Mitochondrial complex I deficiency in Parkinson’s disease. J Neurochem 54:823–827 ArticlePubMedCAS Google Scholar
Jagatha B, Mythri RB, Vali S et al (2008) Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: therapeutic implications for Parkinson’s disease explained via in silico studies. Free Radic Biol Med 44:907–917 ArticlePubMedCAS Google Scholar
Rogers J, Mastroeni D, Leonard B et al (2007) Neuroinflammation in Alzheimer’s disease and Parkinson’s disease: are microglia pathogenic in either disorder? Int Rev Neurobiol 82:235–246 ArticlePubMedCAS Google Scholar
Werner CJ, Heyny-von Haussen R, Mall G et al (2008) Proteome analysis of human substantia nigra in Parkinson’s disease. Proteome Sci 6:8 ArticlePubMed Google Scholar
Braak H, Del Tredici K, Rub U et al (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211 ArticlePubMed Google Scholar
Alladi PA, Mahadevan A, Shankar SK et al (2010) Expression of GDNF receptors GFRalpha1 and RET is preserved in substantia nigra pars compacta of aging Asian Indians. J Chem Neuroanat 40:43–52 ArticlePubMedCAS Google Scholar
Alladi PA, Mahadevan A, Vijayalakshmi K et al (2010) Ageing enhances alpha-synuclein, ubiquitin and endoplasmic reticular stress protein expression in the nigral neurons of Asian Indians. Neurochem Int 57:530–539 ArticlePubMedCAS Google Scholar
Alladi PA, Mahadevan A, Yasha TC et al (2009) Absence of age-related changes in nigral dopaminergic neurons of Asian Indians: relevance to lower incidence of Parkinson’s disease. Neuroscience 159:236–245 ArticlePubMedCAS Google Scholar
Karunakaran S, Saeed U, Mishra M et al (2008) Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-treated mice. J Neurosci 28:12500–12509 ArticlePubMedCAS Google Scholar
Karunakaran S, Saeed U, Ramakrishnan S et al (2007) Constitutive expression and functional characterization of mitochondrial glutaredoxin (Grx2) in mouse and human brain. Brain Res 1185:8–17 ArticlePubMedCAS Google Scholar
Agarwal V, Kommaddi RP, Valli K et al (2008) Drug metabolism in human brain: high levels of cytochrome P4503A43 in brain and metabolism of anti-anxiety drug alprazolam to its active metabolite. PLoS One 3:e2337 ArticlePubMed Google Scholar
Chinta SJ, Kommaddi RP, Turman CM et al (2005) Constitutive expression and localization of cytochrome P-450 1A1 in rat and human brain: presence of a splice variant form in human brain. J Neurochem 93:724–736 ArticlePubMedCAS Google Scholar
Chandana R, Mythri RB, Mahadevan A et al (2009) Biochemical analysis of protein stability in human brain collected at different post-mortem intervals. Indian J Med Res 129:189–199 PubMedCAS Google Scholar
Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358 ArticlePubMedCAS Google Scholar
Mythri RB, Jagatha B, Pradhan N et al (2007) Mitochondrial complex I inhibition in Parkinson’s disease: how can curcumin protect mitochondria? Antioxid Redox Signal 9:399–408 ArticlePubMedCAS Google Scholar
Trounce IA, Kim YL, Jun AS et al (1996) Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol 264:484–509 ArticlePubMedCAS Google Scholar
Bagnyukova TV, Storey KB, Lushchak VI (2003) Induction of oxidative stress in Rana ridibunda during recovery from winter hibernation. J Therm Biol 28:21–28 ArticleCAS Google Scholar
Guthenberg C, Alin P, Mannervik B (1985) Glutathione transferase from rat testis. Methods Enzymol 113:507–510 ArticlePubMedCAS Google Scholar
Tietze F (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 27:502–522 ArticlePubMedCAS Google Scholar
Seelig GF, Meister A (1985) Glutathione biosynthesis; gamma-glutamylcysteine synthetase from rat kidney. Methods Enzymol 113:379–390 ArticlePubMedCAS Google Scholar
Sian J, Dexter DT, Lees AJ et al (1994) Glutathione-related enzymes in brain in Parkinson’s disease. Ann Neurol 36:356–361 ArticlePubMedCAS Google Scholar
Albers DS, Beal MF (2000) Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease. J Neural Transm Suppl 59:133–154 PubMedCAS Google Scholar
Banerjee R, Starkov AA, Beal MF et al (2009) Mitochondrial dysfunction in the limelight of Parkinson’s disease pathogenesis. Biochim Biophys Acta 1792:651–663 PubMedCAS Google Scholar
Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787–795 ArticlePubMedCAS Google Scholar
Schapira AH, Cooper JM, Dexter D et al (1989) Mitochondrial complex I deficiency in Parkinson’s disease. Lancet 1:1269 ArticlePubMedCAS Google Scholar
Schapira AH, Mann VM, Cooper JM et al (1990) Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson’s disease. J Neurochem 55:2142–2145 ArticlePubMedCAS Google Scholar
Jenner P (1993) Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson’s disease. Acta Neurol Scand Suppl 146:6–13 PubMedCAS Google Scholar
Damier P, Hirsch EC, Zhang P et al (1993) Glutathione peroxidase, glial cells and Parkinson’s disease. Neuroscience 52:1–6 ArticlePubMedCAS Google Scholar
Mann VM, Cooper JM, Daniel SE et al (1994) Complex I, iron, and ferritin in Parkinson’s disease substantia nigra. Ann Neurol 36:876–881 ArticlePubMedCAS Google Scholar
Pearce RK, Owen A, Daniel S et al (1997) Alterations in the distribution of glutathione in the substantia nigra in Parkinson’s disease. J Neural Transm 104:661–677 ArticlePubMedCAS Google Scholar
Perry TL, Godin DV, Hansen S (1982) Parkinson’s disease: a disorder due to nigral glutathione deficiency? Neurosci Lett 33:305–310 ArticlePubMedCAS Google Scholar
Perry TL, Yong VW (1986) Idiopathic Parkinson’s disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci Lett 67:269–274 ArticlePubMedCAS Google Scholar
Chinta SJ, Andersen JK (2006) Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson’s disease. Free Radic Biol Med 41:1442–1448 ArticlePubMedCAS Google Scholar
Hsu M, Srinivas B, Kumar J et al (2005) Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells is via an NO-mediated pathway not involving peroxynitrite: implications for Parkinson’s disease. J Neurochem 92:1091–1103 ArticlePubMedCAS Google Scholar
Clementi E, Brown GC, Feelisch M et al (1998) Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci USA 95:7631–7636 ArticlePubMedCAS Google Scholar
Bharath S, Andersen JK (2005) Glutathione depletion in a midbrain-derived immortalized dopaminergic cell line results in limited tyrosine nitration of mitochondrial complex I subunits: implications for Parkinson’s disease. Antioxid Redox Signal 7:900–910 ArticlePubMedCAS Google Scholar
Greenamyre JT, Sherer TB, Betarbet R et al (2001) Complex I and Parkinson’s disease. IUBMB Life 52:135–141 ArticlePubMedCAS Google Scholar
Sian J, Dexter DT, Lees AJ et al (1994) Alterations in glutathione levels in Parkinson’s disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 36:348–355 ArticlePubMedCAS Google Scholar
Riederer P, Sofic E, Rausch WD et al (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 52:515–520 ArticlePubMedCAS Google Scholar
Adams JD Jr, Klaidman LK, Odunze IN et al (1991) Alzheimer’s and Parkinson’s disease. Brain levels of glutathione, glutathione disulfide, and vitamin E. Mol Chem Neuropathol 14:213–226 ArticlePubMedCAS Google Scholar
Chinta SJ, Kumar JM, Zhang H et al (2006) Up-regulation of gamma-glutamyl transpeptidase activity following glutathione depletion has a compensatory rather than an inhibitory effect on mitochondrial complex I activity: implications for Parkinson’s disease. Free Radic Biol Med 40:1557–1563 ArticlePubMedCAS Google Scholar
Frade J, Pope S, Schmidt M et al (2008) Glutamate induces release of glutathione from cultured rat astrocytes–a possible neuroprotective mechanism? J Neurochem 105:1144–1152 ArticlePubMedCAS Google Scholar
Gegg ME, Beltran B, Salas-Pino S et al (2003) Differential effect of nitric oxide on glutathione metabolism and mitochondrial function in astrocytes and neurones: implications for neuroprotection/neurodegeneration? J Neurochem 86:228–237 ArticlePubMedCAS Google Scholar
Sagara J, Makino N, Bannai S (1996) Glutathione efflux from cultured astrocytes. J Neurochem 66:1876–1881 ArticlePubMedCAS Google Scholar
Shih AY, Johnson DA, Wong G et al (2003) Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J Neurosci 23:3394–3406 PubMedCAS Google Scholar
Ramsey CP, Glass CA, Montgomery MB et al (2007) Expression of Nrf2 in neurodegenerative diseases. J Neuropathol Exp Neurol 66:75–85 ArticlePubMedCAS Google Scholar
McGeer PL, Itagaki S, Boyes BE et al (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson’s and Alzheimer’s disease brains. Neurology 38:1285–1291 PubMedCAS Google Scholar
Mirza B, Hadberg H, Thomsen P et al (2000) The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson’s disease. Neuroscience 95:425–432 ArticlePubMedCAS Google Scholar
Bertrand E, Lechowicz W, Szpak GM et al (1997) Qualitative and quantitative analysis of locus coeruleus neurons in Parkinson’s disease. Folia Neuropathol 35:80–86 PubMedCAS Google Scholar
Martin HL, Teismann P (2009) Glutathione–a review on its role and significance in Parkinson’s disease. FASEB J 23:3263–3272 ArticlePubMedCAS Google Scholar
Lin LF, Doherty DH, Lile JD et al (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130–1132 ArticlePubMedCAS Google Scholar